Feasibility of breast conservation after neoadjuvant taxene based chemotherapy in locally advanced breast cancer: a Prospective Phase I trial.
BACKGROUND
Neoadjuvant chemotherapy is the standard care for locally advanced breast cancer. Our study aimed at evaluating the feasibility of breast conversation surgery (BCS) after neoadjuvant chemotherapy.


METHODS
Forty five patients had stage IIB (except those with T2N1 disease) and stage IIIA were selected to 3 cycles taxane-based neoadjuvant chemotherapy. Patient who had tumours ≤5 cm underwent a tentative BCS while patients who had tumour size >5 cm underwent radical surgery. Negative margin is essential for BCS. Adjuvant chemotherapy and 3-D radiotherapy ± hormonal treatment were given to all patients.


RESULTS
Thirty four patients had BCS. Response to chemotherapy was the only statistically significant factor which influences the BCS. Incidence of local recurrence was 5.9% for patients who had BCS at a median follow up 24 months.


CONCLUSIONS
Breast conservation is feasible in selected cases of locally advanced, non metastatic cancer breast. We recommend that patients who have tumour size ≤4 cm after chemotherapy are the best candidates for BCS.
El-Sayed
Mohamed I
MI
Department of Biostatistics and Cancer Epidemiology, South Egypt Cancer Institute, Assiut University, Assiut, Egypt. nabiel@hcp-egypt.com.
Maximous
Doaa W
DW
Aboziada
Mohamed A
MA
Abdel-Wanis
Mostafa E
ME
Mikhail
Nabiel Nh
NN
J Cancer Res Ther. 2007 Apr-Jun;3(2):75-80
17998727
Radiother Oncol. 2000 Oct;57(1):69-77
11033191
J Clin Oncol. 2003 Mar 1;21(5):864-70
12610186
Cancer. 1992 Jun 1;69(11):2849-52
1571916
J Clin Oncol. 1997 Aug;15(8):2873-81
9256131
J Clin Oncol. 1998 Aug;16(8):2672-85
9704717
Indian J Cancer. 2005 Jan-Mar;42(1):30-4
15805689
Cancer. 1994 Jan 15;73(2):362-9
8293401
Ann Surg. 1995 Nov;222(5):612-8
7487207
J Am Coll Surg. 2000 Mar;190(3):350-63
10703863
Cancer J Sci Am. 1998 Mar-Apr;4(2):125-31
9554929
Cancer. 1994 Jul 1;74(1 Suppl):453-65
8004621
Int J Radiat Oncol Biol Phys. 1996 Mar 15;34(5):1019-28
8600084
Clin Drug Investig. 2006;26(12):691-701
17274676
Onkologie. 2005 Jun;28(6-7):339-44
15933422
Ann Surg Oncol. 2002 Apr;9(3):228-34
11923128
Gan To Kagaku Ryoho. 2004 Aug;31(8):1187-92
15332541
Clin Cancer Res. 2004 Oct 1;10(19):6622-8
15475452